Jakmet PG 1mg/500mg/15mg Tablet SR
Marketer
Jakstar Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Jakmet PG 1mg/500mg/15mg Tablet SR
Combiflex DM 1mg/500mg/15mg extended-release tablets manage blood glucose effectively. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex DM 1mg/500mg/15mg extended-release tablets. Take it with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless nearing the next scheduled dose; then, omit the missed dose and resume the regular schedule. Never double the dose. Overdosing can cause hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor of any kidney, liver, or heart conditions before commencing treatment. Pregnant or breastfeeding individuals should consult their doctor. Kidney function will be assessed prior to treatment initiation. Limit alcohol consumption to reduce potential side effects.
Uses of Jakmet PG 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Jakmet PG 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Jakmet PG 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this medication with food.
Common Side effects of Jakmet PG 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Jakmet PG 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Jakmet PG 1mg/500mg/15mg Extended-Release tablet with a meal.
How Jakmet PG 1mg/500mg/15mg Tablet SR works:
Jakmet PG 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Jakmet PG 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Jakmet PG 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Jakmet PG 1mg/500mg/15mg tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Jakmet PG 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Jakmet PG 1mg/500mg/15mg SR tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Jakmet PG 1mg/500mg/15mg SR tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Jakmet PG 1mg/500mg/15mg SR tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Jakmet PG 1mg/500mg/15mg Tablet SR :
Should you forget a Jakmet PG 1mg/500mg/15mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Jakmet PG 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently